NCT07356037尚未招募3 期
A Prospective Clinical Study of Nanocrystalline Megestrol Acetate in Combination With Standard Therapy Versus Standard Therapy Alone for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 68
研究概览
简要总结
This study is a prospective, randomized, parallel-controlled clinical trial. The primary objective is to evaluate the superiority and safety of nanocrystalline megestrol acetate in combination with standard therapy compared with standard therapy alone in improving appetite and body mass index (BMI) during treatment in patients with early-stage or locally advanced hepatocellular carcinoma at the cachexia stage.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hepatocellular carcinoma who have not previously received systemic therapy and are confirmed by histological or cytological assessment, as evaluated by the investigator, to be unsuitable or ineligible for curative surgical resection; Barcelona Clinic Liver Cancer (BCLC) stage B-C.
- •Child-Pugh class A or B
- •Planned to receive interventional therapy in combination with systemic antitumor therapy.
- •At least one measurable tumor lesion according to mRECIST v1.
- •Meet the diagnostic criteria for pre-cachexia or cachexia (based on the Fearon criteria).
排除标准
- •Presence of any condition affecting gastrointestinal absorption, such as dysphagia, malabsorption, or uncontrolled vomiting; patients receiving tube feeding or parenteral nutrition.
- •Presence of anorexia due to anorexia nervosa, psychiatric disorders, or pain that makes eating difficult.
- •Patients with acquired immunodeficiency syndrome (AIDS).
- •Currently receiving or planning to receive other medications that increase appetite or body weight, such as corticosteroids (except short-term dexamethasone during chemotherapy), androgens, progestins, thalidomide, olanzapine, anamorelin, or other appetite stimulants.
- •Patients with Cushing's syndrome, adrenal or pituitary insufficiency, or poorly controlled diabetes mellitus.
研究者
相似试验
招募中
1 期
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut AllergyNCT07287033Mabylon AG48
招募中
不适用
Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell MalignanciesNCT07345728Donghua Zhang28
尚未招募
2 期
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic CancerNCT07301229Shanghai Henlius Biotech100
尚未招募
1 期
A Phase I Trial of Subcutaneous QLS7305 in Healthy AdultsNCT07313150Qilu Pharmaceutical Co., Ltd.60
Enrolling By Invitation
1 期
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UCBladder Urothelial CarcinomaLymph Node MetastasisNCT07353294Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University12